ATE472735T1 - Diagnose von atherosclerose - Google Patents

Diagnose von atherosclerose

Info

Publication number: ATE472735T1
Authority: AT; Austria
Prior art keywords: atherosclerosis; individual; diagnosis; lipoprotein; risk
Prior art date: 2001-02-15

Application number

AT02711114T

Other languages

English (en)

Inventor

Ivan Petyaev

Original Assignee

Petyaev Ivan Mikhailovich

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-15

Filing date

2002-02-15

Publication date

2010-07-15

2002-02-15 Application filed by Petyaev Ivan Mikhailovich filed Critical Petyaev Ivan Mikhailovich

2010-07-15 Application granted granted Critical

2010-07-15 Publication of ATE472735T1 publication Critical patent/ATE472735T1/de

Links

201000001320 Atherosclerosis Diseases 0.000 title abstract 3
238000003745 diagnosis Methods 0.000 title 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
102000004895 Lipoproteins Human genes 0.000 abstract 1
108090001030 Lipoproteins Proteins 0.000 abstract 1
235000012000 cholesterol Nutrition 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pathology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Endocrinology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)
Analysing Materials By The Use Of Radiation (AREA)
Eye Examination Apparatus (AREA)
Mechanical Treatment Of Semiconductor (AREA)
Lubrication Of Internal Combustion Engines (AREA)

AT02711114T 2001-02-15 2002-02-15 Diagnose von atherosclerose ATE472735T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0103766.2A GB0103766D0 (en)	2001-02-15	2001-02-15	Diagnostic
PCT/GB2002/000694 WO2002065137A2 (en)	2001-02-15	2002-02-15	Diagnosis of atherosclerosis

Publications (1)

Publication Number	Publication Date
ATE472735T1 true ATE472735T1 (de)	2010-07-15

Family

ID=9908827

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02711114T ATE472735T1 (de)	2001-02-15	2002-02-15	Diagnose von atherosclerose

Country Status (7)

Country	Link
US (1)	US7713747B2 (de)
EP (1)	EP1366369B1 (de)
AT (1)	ATE472735T1 (de)
AU (1)	AU2002230004A1 (de)
DE (1)	DE60236849D1 (de)
GB (2)	GB0103766D0 (de)
WO (1)	WO2002065137A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8247235B2 (en)	2007-06-08	2012-08-21	Quest Diagnostics Investments Incorporated	Lipoprotein analysis by differential charged-particle mobility
US9354200B1 (en)	2008-08-07	2016-05-31	Quest Diagnostics Investments Incorporated	Detection apparatus for differential-charged particle mobility analyzer
US20100136035A1 (en) *	2008-11-21	2010-06-03	Greenspan Daniel S	Method for modulating atherosclerosis
WO2011046504A1 (en) *	2009-10-18	2011-04-21	Glycorex Ab	Method and product for blood treatment and purification
US9250211B2 (en)	2010-12-30	2016-02-02	Quest Diagnostics Investments Incorporated	Magnetic separation of lipoproteins using dextran sulfate
MX2014006673A (es) *	2011-12-07	2014-09-04	Amgen Inc	Separacion de la isoforma de disulfuro de la igg2.
US11456022B2 (en)	2020-06-30	2022-09-27	Western Digital Technologies, Inc.	Distributed grouped terminations for multiple memory integrated circuit systems
US11302645B2 (en)	2020-06-30	2022-04-12	Western Digital Technologies, Inc.	Printed circuit board compensation structure for high bandwidth and high die-count memory stacks

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4018886A (en) *	1975-07-01	1977-04-19	General Electric Company	Diagnostic method and device employing protein-coated magnetic particles
DE2836046A1 (de) *	1978-08-17	1980-02-28	Behringwerke Ag	Immunologisches bestimmungsverfahren
US5985578A (en) *	1991-08-09	1999-11-16	Washington University	Autoantibodies and their targets in the diagnosis of peripheral neuropathies
US5753227A (en) *	1993-07-23	1998-05-19	Strahilevitz; Meir	Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
AU7707294A (en) *	1993-09-29	1995-04-18	Yamasa Corporation	Method of assaying oxidized lipoprotein and application thereof
EP1037663A2 (de) *	1997-12-16	2000-09-27	Regents Of The University Of Minnesota	Verfahren zur behandlung unerwünschter immunantworten

2001
- 2001-02-15 GB GBGB0103766.2A patent/GB0103766D0/en not_active Ceased
2002
- 2002-02-15 EP EP02711114A patent/EP1366369B1/de not_active Expired - Lifetime
- 2002-02-15 DE DE60236849T patent/DE60236849D1/de not_active Expired - Lifetime
- 2002-02-15 WO PCT/GB2002/000694 patent/WO2002065137A2/en not_active Ceased
- 2002-02-15 AU AU2002230004A patent/AU2002230004A1/en not_active Abandoned
- 2002-02-15 GB GB0321080A patent/GB2389905B/en not_active Expired - Fee Related
- 2002-02-15 AT AT02711114T patent/ATE472735T1/de not_active IP Right Cessation
- 2002-02-15 US US10/468,073 patent/US7713747B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20040137542A1 (en)	2004-07-15
AU2002230004A1 (en)	2002-08-28
WO2002065137A3 (en)	2003-05-30
GB0103766D0 (en)	2001-04-04
US7713747B2 (en)	2010-05-11
GB2389905A (en)	2003-12-24
GB2389905B (en)	2004-10-06
EP1366369B1 (de)	2010-06-30
EP1366369A2 (de)	2003-12-03
DE60236849D1 (de)	2010-08-12
GB0321080D0 (en)	2003-10-08
WO2002065137A2 (en)	2002-08-22

Similar Documents

Publication	Publication Date	Title
ATE540319T1 (de)	2012-01-15	Verfahren für die bestimmung von fk506
ATE386970T1 (de)	2008-03-15	Zugriffs- und benutzungsmethoden für webseiten
WO2005042761A3 (en)	2007-01-11	Biomarkers for amyotrophic lateral sclerosis
ATE491953T1 (de)	2011-01-15	Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
EP1239438A3 (de)	2003-02-19	System zur überprüfung der Antworten zu Testfragen
WO2006081437A3 (en)	2007-07-26	Method and system for identifying illumination flux in an image
NO20015096D0 (no)	2001-10-19	Måling og bruk av molekul¶re interaksjoner
EP1580551A4 (de)	2010-09-15	Membran zur trennung von plasma oder serum und filter vorrichtung mit der membran zur trennung von plasma oder serum
DE69836888D1 (de)	2007-03-08	Verfahren für Fluoreszenzerkennungstest
DE50003766D1 (de)	2003-10-23	Verfahren und vorrichtung zum nachweis und zur quantifizierung von biomolekülen
DE69925929D1 (de)	2005-07-28	Verfahren zur diagnose von isolationsverschlechterungen in unterirdischen kabeln
DE60103451D1 (de)	2004-07-01	Verfahren und Vorrichtung für das Simulieren von Lasten an Hebezeugen
DE69725606D1 (de)	2003-11-20	Methoden für die diagnose von allergischen atemwegsaspergillosen
DE60236849D1 (de)	2010-08-12	Diagnose von atherosclerose
ATE370414T1 (de)	2007-09-15	Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE404118T1 (de)	2008-08-15	System für kontinuierliche leistungstests
ATE529533T1 (de)	2011-11-15	Verfahren zum nachweis von analyten in einer probe
ATE306659T1 (de)	2005-10-15	Küvette für ein lesegerät zur bestimmung von substanzen mittels der evaneszenzfeldmethode
DE50007635D1 (de)	2004-10-07	Verfahren zur diagnose von sjögren-syndrom
EP1281083A4 (de)	2004-11-17	Verfahren zur erkennung von entzündungen und entzündungsbedingungen
WO2000050904A8 (de)	2001-04-12	Testkit zur analytik der faktor-viii-spaltenden protease
ATE442456T1 (de)	2009-09-15	Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs
ATE483983T1 (de)	2010-10-15	Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
DE60026285D1 (de)	2006-04-27	Verfahren zur abschätzung des individuellen risikos einer irreversiblen nervenschädigung, das schritte zur quantitativen bestimmung der pepsinogen-i (pgi) und vitamin b12 konzentrationen umfasst
DE60232529D1 (de)	2009-07-16	Verfahren und vorrichtung zur isolierung und/oder bestimmung eines analyten

Legal Events

Date	Code	Title	Description
2010-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties